Mapping and Characterization of Alveolar Cells During Smoking and Chronic Obstructive Disease
Recruiting · NCT05227547 · Interventional (participants receive a specific treatment) · Lead sponsor: Centre Hospitalier Intercommunal Creteil
View the official record on ClinicalTrials.gov →Interventions studied
Thoracic resection surgery
What this trial is about
To evaluate the regenerative capacities of mesenchymal cells composing the microenvironment of alveolar type 2 cells in a population of patients, undergoing thoracic surgery for suspected cancer, who are smokers with and without COPD compared to non-smokers patients
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Age ≥ 18
- Patient undergoing lung resection surgery (lobectomy, pneumonectomy, segmentectomy) for cancer or suspected cancer
- Acceptance to participate in the protocol
- Affiliated to a social security plan
Exclusion criteria
- Chronic autoimmune disease
- Patient under guardianship or curators
- Neo-adjuvant chemotherapy
- History of thoracic radiotherapy
- Pregnant woman
- Minor patient
- Person not able to consent
- Person deprived of liberty
Where it is running
4 locations listed.
- Rousseau-Bussac - Créteil, France
- Hopital Cochin - Paris, France
- HEGP - Paris, France
- Hopital Tenon - Paris, France